Novartis Can't Nix FCA Suit Alleging MS Drug Kickbacks

By Gina Kim · March 31, 2026, 9:41 PM EDT

Novartis must face a False Claims Act suit alleging it improperly had doctors prescribe its multiple sclerosis drug, a New York federal judge said Monday, finding the relator plausibly pled scienter...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States of America ex rel. Steven M. Camburn et al. v. Novartis Pharmaceuticals Corporation

Case Number

1:13-cv-03700

Court

New York Southern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

May 31, 2013